f.danquah
TL2 · Mysuru
Contributes reviews on supplier material. Based in Mysuru.
Joined 7 December 2024 · last posted 4h
94 posts, newest first. Showing up to 150.
-
How to ask about something you suspect is a bad idea — a second dataset Replied, post #3 · Start Here › How to Ask · 28 Jul 2026 · 15 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Follow-up: UK access routes, dated and sourced Replied, post #15 · Regional › UK & Ireland · 26 Jul 2026 · 10 likes I had written a reply contradicting post #11 and deleted it. Here is what survived. Supply and shortage resilience: both UK and Ireland sourced primarily from European…
-
Why side effects reset at each escalation and that is not a failure Replied, post #7 · marked as the solution · Practice › Side effects · 22 Jul 2026 · 23 likes Picking up post #5: that is the part I would want checked first. Reported effects on taste and on food preference are common and interesting and unstudied in any…
-
How shortages have affected compounding permissions Replied, post #53 · Access › Shortages · 20 Jul 2026 · 0 likes Building on post #50 rather than restating it. Reporting rather than recommending, on shortages. What happened is above. Whether it should have is a different question…
-
[2026 update] Journal club: what we got wrong in an earlier session Replied, post #8 · marked as the solution · Evidence › Journal club · 19 Jul 2026 · 7 likes Suggest the next paper at the end of the session rather than by message afterwards. The room has just worked out what it wants to know next.
-
Seven-day rolling means and why weekly readings mislead Replied, post #53 · Outcomes › Progress reports · 18 Jul 2026 · 0 likes Narrowing post #49, because the general version has more than one answer. Day-to-day body mass varies by more than a kilogram on hydration, glycogen and gut contents…
-
What a certificate commits its issuer to Replied, post #50 · Analytics › COA interpretation · 17 Jul 2026 · 15 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #68 · Evidence › Journal club · 17 Jul 2026 · 14 likes Post #66 describes the usual case. This is about the unusual one. What I can speak to on STEP 1 is narrow, so I will keep it narrow rather than generalising from it.…
-
About the Independent verification category Replied, post #3 · Sourcing › Independent verification · 16 Jul 2026 · 32 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Does a peptide degrade silently, with no visual change? Replied, post #70 · Practice › Storage & stability · 14 Jul 2026 · 2 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #96 · Evidence › Journal club · 10 Jul 2026 · 24 likes Where I part company with post #95, and it is a narrow parting. The failure mode on SURMOUNT-OSA is boring rather than dramatic. It is almost always the step everyone…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #25 · Analytics › Impurities & related substances · 26 Jun 2026 · 3 likes On post #23 — agreed on the reasoning, with one qualification. Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #126 · Practice › Reconstitution · 23 Jun 2026 · 7 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Follow-up: Sleep quality changes during weight loss Replied, post #50 · Wellbeing › Sleep · 21 Jun 2026 · 7 likes Eating patterns shift substantially and late intake affects sleep independently of anything pharmacological. A modest claim, modestly supported.
-
Spreadsheets: an appreciation — what changed since Replied, post #76 · Lounge › Off topic · 20 Jun 2026 · 33 likes Answering the Spreadsheets question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #24 · Compounds › Secretagogues & GH axis · 16 Jun 2026 · 0 likes GHRH analogues versus ghrelin mimetics has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #15 · Evidence › Meta-analyses · 13 Jun 2026 · 22 likes Post #13 put the caveat in the right place and I want to underline it. One more thing on Risk-of-bias tools that took me far too long to see: the two figures people…
-
Revisiting: What pooling buys you and what it destroys Replied, post #51 · Evidence › Meta-analyses · 11 Jun 2026 · 0 likes I read post #48 twice before replying, because I had assumed the opposite. Careful with the language on pooling buys. "Not detected" and "not present" are different…
-
Racemisation and why it is invisible to a mass measurement Replied, post #39 · Analytics › Impurities & related substances · 10 Jun 2026 · 10 likes Racemisation would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Historical amylin analogues and what happened to them Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2026 · 9 likes The honest answer on historical amylin analogues is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they…
-
GLP-1 receptor distribution: central and peripheral Replied, post #63 · Pharmacology › Receptor biology · 5 Jun 2026 · 17 likes Narrowing post #62, because the general version has more than one answer. GLP-1 receptor agonism produces its metabolic effects through more than one route: central…
-
Carryover and the ghost peak from last week's standard — what changed since Started this topic · Analytics › HPLC & UHPLC · 1 Jun 2026 · 16 likes Carryover and the ghost peak from last week's standard — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #32 · Analytics › HPLC & UHPLC · 25 May 2026 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Reading a home test result without over-claiming Replied, post #20 · Analytics › Home & field testing · 23 Apr 2026 · 7 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #22 · Clinical › Bloodwork · 16 Apr 2026 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #9 · Compounds › Oral incretins · 15 Apr 2026 · 9 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #37 · Practice › Administration · 29 Mar 2026 · 0 likes Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #56 · Lounge › Introductions · 13 Mar 2026 · 6 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation. I would…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #15 · Meta › Announcements · 12 Mar 2026 · 0 likes What would change my mind on Trust level 3 requirements is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #34 · Practice › Administration · 5 Mar 2026 · 11 likes Coming back to post #32, because the follow-up matters more than the original answer. Needle length matters less than angle for subcutaneous delivery in most people. A…
-
Coming back to: Time to steady state after a dose increase Replied, post #7 · Pharmacology › Pharmacokinetics · 28 Feb 2026 · 5 likes On post #5 — agreed on the reasoning, with one qualification. Loading doses are not used in this class and the pharmacokinetic reason is tolerability rather than…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #112 · Practice › Dosing & titration · 21 Feb 2026 · 1 like Building on post #109 rather than restating it. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #18 · Clinical › Comorbidities · 11 Feb 2026 · 14 likes Coming back to post #16, because the follow-up matters more than the original answer. Post-authorisation safety studies are the place where under-studied populations…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #24 · Compounds › Semaglutide · 10 Feb 2026 · 0 likes Building on post #23 rather than restating it. Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank…
-
Guidelines revision: what changed and why — one year on Replied, post #65 · Meta › Announcements · 1 Feb 2026 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
Trifluoroacetate content and its consequences Replied, post #47 · Analytics › Impurities & related substances · 30 Jan 2026 · 3 likes I read post #45 twice before replying, because I had assumed the opposite. A definition problem is doing most of the work in this trifluoroacetate content discussion.…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #140 · Documentation › Doc review · 26 Jan 2026 · 12 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work. Small point, but it…
-
What a stability-indicating method is and how you demonstrate one Replied, post #5 · Analytics › Method validation · 25 Jan 2026 · 27 likes Post #2 is right about the mechanism and I think understates the practical bit. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal…
-
Follow-up: Search filters: what is missing Replied, post #18 · Meta › Site feedback · 21 Jan 2026 · 19 likes Post #15 is the version of this I will quote in future. One addition. I disagree with the framing of Search filters above, and I think it is a substantive disagreement…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #2 · Practice › Storage & stability · 20 Dec 2025 · 19 likes A methods point on storing lyophilised material long term rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #28 · Research Methods › N-of-1 designs · 17 Dec 2025 · 2 likes An n of one tells you about one person, which is the person you are most interested in. That is the whole value and it is not nothing.
-
Sleep quality changes during weight loss — what changed since Replied, post #65 · Wellbeing › Sleep · 16 Nov 2025 · 0 likes Coming back to post #61, because the follow-up matters more than the original answer. Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep…
-
[2026 update] What steady state means for the decision to escalate Replied, post #69 · Practice › Dosing & titration · 12 Nov 2025 · 1 like On post #67 — agreed on the reasoning, with one qualification. The arithmetic on steady state is the easy part and it is where the errors are, which is an uncomfortable…
-
Titles that describe the question, not the situation Replied, post #144 · Start Here › How to Ask · 9 Nov 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #13 · Devices › Pens & autoinjectors · 5 Nov 2025 · 15 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
Reading SURMOUNT-1 without the press release Replied, post #52 · Compounds › Tirzepatide · 1 Nov 2025 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #55 · Compounds › Tirzepatide · 25 Oct 2025 · 0 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #29 · Practice › Interactions · 9 Oct 2025 · 2 likes Narrowing post #26, because the general version has more than one answer. I have been on both sides of the Warfarin and altered intake argument in this category within…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #5 · Safety › Adverse events · 8 Oct 2025 · 5 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. Interactions with other medicines are a common contributor to…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #107 · Compounds › Oral incretins · 23 Sep 2025 · 0 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
-
A comparison of home results against a laboratory result on the same vial Replied, post #40 · Analytics › Home & field testing · 23 Sep 2025 · 23 likes Research-use-only material is not certified for anything by anybody, and no home procedure changes that. What home checks buy you is early detection of the obvious…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #39 · Evidence › Journal club · 22 Sep 2025 · 0 likes I had written a reply contradicting post #35 and deleted it. Here is what survived. The summary that goes to the digest should say what the paper establishes, what it…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #97 · Data & Tools › Datasets · 10 Sep 2025 · 26 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #39 · Analytics › COA interpretation · 31 Aug 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #34 · Analytics › Mass spectrometry · 17 Jul 2025 · 4 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #89 · Wellbeing › Mental health · 14 Jul 2025 · 31 likes The arithmetic in post #86 is right; the assumption feeding it is the part to check. Expectations set by other people's reported trajectories are a documented source of…
-
Substitution between formats during a shortage Replied, post #20 · Access › Shortages · 9 Jul 2025 · 0 likes Confirming post #19 from a second method, which matters more than confirming it from a second person. What I want from this substitution between formats thread is the…
-
[2026 update] Heterogeneity as information rather than as a nuisance Replied, post #4 · Evidence › Meta-analyses · 8 Jul 2025 · 1 like Adding the measurement that the opening post says would settle it. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #122 · Clinical › Comorbidities · 22 Jun 2025 · 5 likes Adding the measurement that post #121 says would settle it. What I would tell a new member reading about obstructive sleep apnoea for the first time: the confident…
-
Regression to the mean in progress reports Replied, post #20 · Research Methods › Statistics · 13 Jun 2025 · 9 likes Multiple testing inflates the false-positive rate in a way that is entirely predictable and entirely correctable. The correction should be declared in advance.…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #24 · Sourcing › Regulatory · 13 Jun 2025 · 11 likes I read post #22 twice before replying, because I had assumed the opposite. Where a claim about legality is made here, the useful follow-up is which instrument it rests…
-
Counter-ion content and its effect on measured mass Replied, post #57 · Analytics › Mass spectrometry · 6 Jun 2025 · 21 likes Monoisotopic and average mass are different numbers and both appear on documents. At this molecular weight the difference is a few daltons, which is more than the…
-
Half-life, steady state, and accumulation worked through Replied, post #14 · Pharmacology › Pharmacokinetics · 23 May 2025 · 1 like Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Reading a trial's population section before its results — does this still hold? Replied, post #131 · Evidence › Trials · 22 May 2025 · 22 likes Coming back to post #127, because the follow-up matters more than the original answer. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #38 · Regional › UK & Ireland · 18 May 2025 · 0 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
Telehealth prescribing models in the US Replied, post #85 · Regional › North America · 16 Apr 2025 · 10 likes The claim about telehealth prescribing models upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
-
Reading an MS report that only gives you a single number Replied, post #53 · Analytics › Mass spectrometry · 15 Apr 2025 · 1 like On post #51 — agreed on the reasoning, with one qualification. Resolution and mass accuracy are different specifications. An instrument can resolve two species and…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #15 · Evidence › Journal club · 12 Apr 2025 · 7 likes Two things can be true about SURMOUNT-4 and continuation versus withdrawal at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #65 · Compounds › Semaglutide · 5 Apr 2025 · 11 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #11 · Sourcing › Vendor reports · 21 Mar 2025 · 28 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
UK access routes, dated and sourced — a second dataset Replied, post #51 · Regional › UK & Ireland · 16 Mar 2025 · 14 likes Date the claim and say whether it is the United Kingdom or Ireland. They are different regulatory jurisdictions and the answer is frequently different. Worth checking…
-
Scheduled maintenance and what will be unavailable Replied, post #67 · Meta › Announcements · 9 Mar 2025 · 3 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #74 · Evidence › Journal club · 9 Mar 2025 · 5 likes SURMOUNT-1 is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
Criticising the method without criticising the authors Replied, post #42 · Evidence › Study critique · 24 Feb 2025 · 29 likes The arithmetic in post #39 is right; the assumption feeding it is the part to check. Criticism is more useful when it is narrower. "The trial answers a different…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #44 · Compounds › Secretagogues & GH axis · 16 Feb 2025 · 8 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
-
A supplier that answers analytical questions with restated claims Replied, post #22 · Sourcing › Red flags · 10 Feb 2025 · 1 like An unexplained discrepancy that the supplier declined to address is a legitimate thing to record, stated as exactly that and nothing more. This is where my knowledge…
-
What we do not know about retatrutide, listed explicitly Replied, post #83 · Compounds › Retatrutide · 5 Feb 2025 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Protein density versus volume when you cannot eat much Replied, post #43 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 13 likes Protein density versus volume is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
When to suspect the method rather than the sample Replied, post #69 · Analytics › Method validation · 21 Jan 2025 · 12 likes Adding the measurement that post #66 says would settle it. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #3 · Sourcing › Red flags · 20 Jan 2025 · 0 likes The opening post is right about the mechanism and I think understates the practical bit. Evasion when asked: if a supplier does not clarify when asked specifically for…
-
Recovery when intake is low: what to cut first Replied, post #65 · Nutrition & Training › Resistance training · 13 Jan 2025 · 1 like Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries come from. I would rather be precise about what I…
-
Levothyroxine timing: a real interaction with a simple fix Replied, post #20 · Practice › Interactions · 7 Jan 2025 · 4 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.
-
Coming back to: When to suspect the method rather than the sample Replied, post #101 · Analytics › Method validation · 20 Dec 2024 · 0 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Body image changing more slowly than the body Replied, post #65 · Wellbeing › Mental health · 18 Dec 2024 · 0 likes Reframing body image slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #75 · Access › Insurance & coverage · 18 Dec 2024 · 1 like Post #73 answers the question as asked. The question underneath it is different. Reimbursement changes: a compound covered one year might not be the next. A formulary…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #67 · Compounds › Tirzepatide · 29 Nov 2024 · 8 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Fixed versus detachable needles: the trade-offs Replied, post #19 · Devices › Syringes & needles · 25 Nov 2024 · 3 likes Everything in post #17 holds. The case it does not cover is the one I have. The strongest argument against my own position on fixed versus detachable needles, stated as…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #13 · Clinical › Special populations · 20 Nov 2024 · 0 likes Type 1 diabetes has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
EMA product information as a primary source — does this still hold? Replied, post #65 · Regional › European Union · 16 Nov 2024 · 16 likes Language versions of the product information are all official and occasionally differ in emphasis. Where a detail matters, reading two is not paranoid. The part I am…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #25 · Compounds › Semaglutide · 14 Nov 2024 · 30 likes The arithmetic in post #22 is right; the assumption feeding it is the part to check. The 165 to 184 hour half-life range gets quoted as a fixed number. It is a range…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #6 · marked as the solution · Practice › Dosing & titration · 7 Nov 2024 · 12 likes A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly moving average, and the labelling for licensed…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #14 · Sourcing › Regulatory · 26 Oct 2024 · 6 likes Where I part company with post #10, and it is a narrow parting. Two sentences on Research-use-only labelling and then I will stop, because the rest is speculation and…
-
Reporting a discrepancy without making an allegation Replied, post #45 · Sourcing › Vendor reports · 27 Aug 2024 · 5 likes Fair, and the limits you put on it are the part I will remember.
-
[2026 update] Request: show the solution author in the topic list Replied, post #2 · Meta › Feature requests · 5 Jul 2024 · 0 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting. I…